Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy W Schacker

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
JAMA Internal Medicine|November 25, 2014
Defining success with antiretroviral therapyTimothy W Schacker
Trends in Immunology|May 23, 2012
Lymphoid tissue structure and HIV-1 infection: life or death for T cellsMing Zeng, Ashley T Haase, Timothy W Schacker
The Journal of Infectious Diseases|January 21, 2006
Abnormal presence of semimature dendritic cells that induce regulatory T cells in HIV-infected subjectsMitchell D Krathwohl, Timothy W Schacker, Jodi L Anderson
Seminars in Immunology|July 4, 2008
The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ nicheJacob D Estes, Ashley T Haase, Timothy W Schacker
Current Opinion in HIV and AIDS|March 5, 2013
Overcoming pharmacologic sanctuariesTheodore J Cory, Timothy W Schacker, Mario Stevenson, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 6, 2005
Ex vivo modeling of oral HIV transmission in human palatine tonsilDiane M Maher, Zhi-Qiang Zhang, Timothy W Schacker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 12, 2010
A role for syndecan-1 and claudin-2 in microbial translocation during HIV-1 infectionAnthony J Smith, Timothy W Schacker, Cavan S Reilly, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2002
Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled studyTimothy W Schacker, Marcus Conant, Christopher Thoming, et al.
Plos One|June 11, 2016
Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital MucosaJoshua T Schiffer, David A Swan, Amalia Magaret, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 12, 2010
Host genes associated with HIV-1 replication in lymphatic tissueAnthony J Smith, Qingsheng Li, Stephen W Wietgrefe, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
JAMA Internal Medicine|November 25, 2014
Defining success with antiretroviral therapyTimothy W Schacker
Trends in Immunology|May 23, 2012
Lymphoid tissue structure and HIV-1 infection: life or death for T cellsMing Zeng, Ashley T Haase, Timothy W Schacker
The Journal of Infectious Diseases|January 21, 2006
Abnormal presence of semimature dendritic cells that induce regulatory T cells in HIV-infected subjectsMitchell D Krathwohl, Timothy W Schacker, Jodi L Anderson
Seminars in Immunology|July 4, 2008
The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ nicheJacob D Estes, Ashley T Haase, Timothy W Schacker
Current Opinion in HIV and AIDS|March 5, 2013
Overcoming pharmacologic sanctuariesTheodore J Cory, Timothy W Schacker, Mario Stevenson, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 6, 2005
Ex vivo modeling of oral HIV transmission in human palatine tonsilDiane M Maher, Zhi-Qiang Zhang, Timothy W Schacker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 12, 2010
A role for syndecan-1 and claudin-2 in microbial translocation during HIV-1 infectionAnthony J Smith, Timothy W Schacker, Cavan S Reilly, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2002
Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled studyTimothy W Schacker, Marcus Conant, Christopher Thoming, et al.
Plos One|June 11, 2016
Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital MucosaJoshua T Schiffer, David A Swan, Amalia Magaret, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 12, 2010
Host genes associated with HIV-1 replication in lymphatic tissueAnthony J Smith, Qingsheng Li, Stephen W Wietgrefe, et al.
Pageof 9